The Democratic Republic of the Congo (DRC) harbors 11% of global malaria cases, yet little is known 42 about the spatial and genetic structure of the parasite population in that country. We sequenced 2537 43 Plasmodium falciparum infections, including a nationally representative population sample from DRC 44 and samples from surrounding countries, using molecular inversion probes -a novel high-throughput 45 genotyping tool. We identified an east-west divide in haplotypes known to confer resistance to 46 chloroquine and sulfadoxine-pyrimethamine. Furthermore, we identified highly related parasites over 47 129 Complexity of infection: Initial analyses focused on the genome-wide MIP panel only. Complexity of 130 infection (COI) for each sample was estimated using THE REAL McCOIL 13 (Supplemental Figure 3) . 131
large geographic distances, indicative of gene flow and migration. Our results were consistent with a 48 background of isolation by distance combined with the effects of selection for antimalarial drug 49 resistance. This study provides a high-resolution view of parasite genetic structure across a large 50 country in Africa and provides a baseline to study how implementation programs may impact parasite 51 populations. 52 3 BACKGROUND 53 54 Malaria remains one of the largest global public health challenges, with an estimated 219 million cases 55 worldwide in 2017 1 . Despite decades of scale-up in control, there has been a recent resurgence, 56 particularly in high transmission countries in sub-Saharan Africa 1 . In addition, the emergence of 57 antimalarial resistance poses a major threat to current control and elimination efforts worldwide, and 58 new tools are needed to quantify the changing landscape of drug resistance on timescales relevant to 59 malaria control programmes. Genomics has emerged as a useful method for better understanding 60 parasite populations that can be leveraged to support the design of effective interventions against a 61 continually evolving parasite. 62
63
Data from genomic studies provides information that is complementary to epidemiological data 2 , and 64
can help to answer several key questions, including how parasites are transmitted, how drug resistance 65 spreads, and how malaria control efforts impact the diversity of the parasite population. However, to 66 date, efforts to use genomics to inform malaria control efforts have suffered from three major 67 limitations. First, much of the work has been conducted in low transmission regions, such as Asia and 68 transmission fringe regions of Africa, leaving it unclear how useful information can be gathered in the 69 highest transmission settings. Some of these high burden regions have experienced increasing malaria 70 prevalence in recent years and are now the center of strategic plans for control efforts 3, 4 . Second, most 71 genomic studies in Africa have relied upon convenience sampling from a few sites usually collected for 72 other purposes, rather than population-representative samples. Lastly, studies have either relied on 73 relatively few genetic markers, providing limited insight into the complete genome, or on expensive 74 whole genome sequencing, limiting the number of samples studied. Overcoming these limitations is 75 essential for genomics to have broader impacts on malaria control. 76 77 Within Africa, parasite populations have been shown to vary significantly between East and West, as 78 demonstrated by their distinct antimalarial drug susceptibilities and population genetics 5,6 . However, few 79 genomic studies have incorporated samples from central Africa, limiting our understanding of the 80 connectivity of parasite populations across the continent. The Democratic Republic of the Congo (DRC) 81 is the largest malaria-endemic country in Africa, borders nine countries and harbors approximately 11% 82 of global P. falciparum malaria cases 1 . The DRC harbors a large, understudied parasite population that 83 likely serves as a bridge between African parasite populations. Limited previous work has shown that 84 the DRC represents a watershed between East and West African drug resistant parasite populations for 85 sulfadoxine-pyrimethamine and chloroquine resistance 7-9 . More recently, parasite population structuring 86 4 due to mutations at these and other loci associated with antimalarial resistance has been confirmed 87 within the DRC 10 . However, studies focusing on hypervariable surface antigen diversity or neutral 88 microsatellites have been unable to detect significant structure in the parasite population 10,11 , likely due 89 to a lack of high-quality genome-wide signal. A better understanding of parasite populations and the 90 spread of antimalarial resistance in the DRC will allow for the design of more effective interventions 91 accounting for evolutionary forces. 92
93
To address this knowledge gap, we leveraged a recent advance in malaria genomics, high-throughput 94 molecular inversion probe (MIP) capture and sequencing, to characterize and map parasite population 95 structure and antimalarial resistance profiles in the DRC and to define the connections of parasites 96 within the DRC to East and West African parasite populations 12 . This approach provides a cost-97 effective and scalable method of genome interrogation, without the expense or informatic complexities 98 of whole genome sequencing. We previously employed MIPs to comprehensively genotype known 99 antimalarial resistance genes in several hundred samples from the DRC 10 . Here, we introduce an 100 expanded MIP panel targeted at 1834 single nucleotide polymorphisms (SNPs) distributed throughout 101 the P. falciparum genome, and designed to quantify differentiation and relatedness between samples. were concentrated in a region on chromosome seven in close proximity to P. falciparum chloroquine 155 resistance transporter (pfcrt), a known drug resistance locus, suggesting that resistance to chloroquine 156 or amodiaquine may be driving differentiation along this secondary axis. For PC3, locus contributions 157 were concentrated in three genic regions: PF3D7_0215300 (8.5%), PF3D7_0220300 (5.0%), and 158 PF3D7_1127000 (4.3%). The first and largest of these encodes an acyl-CoA synthetase and is part of a 159 diverse gene family known to undergo extensive gene conversion and recombination 14 . For PC4 we 160 observed a region of high locus contribution on chromosome eight in close proximity to the known 161 antifolate drug resistance gene dihydropteroate synthase (dhps). Combined, these results suggest that 162 geography and drug resistance are both contributors to the observed population structure. 163 164 7
The relationship between the PCA results and the spatial distribution of parasites was explored by 165 plotting raw principal component values against the geographic location of samples (Figure 3a-3d ). For 166 PC1 this revealed a complex pattern of spatial variation, containing both north-south and east-west 167 clines. For PC2 and PC4 the maps essentially recapitulate the known geographic distribution of pfcrt 168 and dhps resistance mutations, respectively (Figure 3e-3f) . For PC3 the map indicates some east-west 169 spatial structuring that is not explained by known markers of antimalarial resistance and warrants 170 further investigation. 
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Mean IBD was significantly higher within clusters compared to between clusters (0.06 vs. 0.02, two-191 sample t-test, p<0.001). When plotted against geographic separation there was a clear fall-off of IBD 192 with distance (Figure 5a) , consistent with the classical pattern expected under isolation-by-193 distance 16, 17 . Focussing on the tail of highly related samples, which includes the major strain in complex 194 infections, there were 12 sample pairs with a relatedness greater than IBD=0.9. Comparison of raw 195 allele frequency distributions confirmed that these were likely clones (Supplemental Figure 6) . These 196 highly related pairs were found more often within the same cluster than in different clusters (7 vs. 5 197 respectively, chi-squared test, p<0.001), suggesting the presence of local clonal transmission chains. 198
The five between-cluster highly related pairs (Figure 5b (Supplemental Figure 7) . The 210 prevalence of every mutation identified by the drug resistance MIP panel was calculated in eastern and 211 western DRC, as well as at the country level. Table 1 gives a summary of all mutations that reached a 212 prevalence >5% in any geographic unit, and a complete list of all identified mutations along with their 213 prevalence is given in Supplemental Table 2 . Note that in the dhps mutation G437A the reference is 214 resistant, hence this is re-coded as A437G and prevalence values indicate the prevalence of the 215 reference allele. Estimated prevalences of these alleles in the DRC as a whole were broadly similar to 216 previously published estimates 10 . However, we did identify several polymorphisms in known and 217 putative resistance genes not previously reported in the DRC, including kelch K189T and pfatp6 218 N569K, both of which have been described at appreciable frequencies elsewhere in Africa 18-20 . 219 
252
Mutations in dhps were more difficult to interpret. This gene has undergone multiple selective sweeps 253 associated with increasing drug resistance. The most recently introduced mutation into the DRC, dhps 254 A581G, showed relatively conserved local haplotypes around the mutation in both eastern and western 255 DRC (Supplemental Figure 9) . Extended haplotypes around the other mutations (Supplemental 256 Figures 10 and 11) are inconsistent with a classical hard sweep, perhaps due to selection on multiple 257 independent haplotypes or to interference between A581G and other linked alleles. Finally, we did not 258 detect any strong signals of differing patterns of recent positive selection between the eastern and 259 western DRC among the dhfr and mdr2 genes (Supplemental Table 3, Supplementary Figure 12) . Here we provide the first large-scale, robustly sampled study of falciparum malaria in central Africa 271 using MIP capture and sequencing, a novel high-throughput genotyping approach that is appropriate for 272 large population based surveys. Using a panel of probes designed to detect genome-wide SNPs, 273 combined with a second panel targeting drug resistance genes, we were able to show that the parasite 274 population in the DRC contains a signal of differentiation by geographic separation, consistent with the 275 classical pattern of isolation by distance. This background population structure is overlaid with the clear 276 impacts of drug resistance mutations, which cause distinct structure between East and West African 277 parasite populations. Additionally, the use of relatively dense genome-wide SNPs allowed us to carry 278 out relatedness analysis, revealing a handful of cases where human hosts separated by many 279 hundreds of kilometers were infected by essentially identical clones. Given the rapid breakdown of 280 distinct genotypes by recombination in high transmission areas, it is highly likely that these events 281 represent relatively recent infection and migration events. With this in mind, it is interesting to note that 282 pairwise links of high relatedness tend to fall along the Congo River, an important route of 283 transportation in DRC. Lastly, the combination of the two MIP panels allowed us to examine extended 284 haplotypes surrounding drug resistance genes, revealing rapid breakdown of haplotypes in the 285 population and different signals of selection in East vs. West DRC. 286
287
We previously investigated population structure using MIPs targeting 20 microsatellites in the DRC 10 , 288 failing to detect a strong signal of population structure based upon these markers. Here we leveraged 289 the same 552 samples as the previous study, plus additional samples from the DRC and neighboring 290 countries, to identify clear structure with an improved SNP-based genotyping method. Our ability to 291 detect population structure in the present study is likely due to several factors. First, the new SNP panel 292 contains nearly two orders of magnitude more markers than the previous panel. While this new SNP 293 MIP panel expanded the number of loci interrogated, we have yet to achieve the full potential of MIPs. 294
Specifically, massively increased, multiplexed probe sets that target additional portions of the genome 295 are feasible. MIPs have now been used in human studies to detect as many as 55,000 markers in a 296 single reaction 22 . Second, a large number of genome-wide SNPs in this study were chosen based on 297 high FST values in publicly available samples from surrounding countries. This increases our power to 298 detect geographic differentiation, but comes at the cost of not being able to comment on the relative 299 importance of geography vs. drug resistance, which would require random genetic sampling or 300 alternatively whole genomes. Similarly, we should be cautious when interpreting spatial clines in 301 population structure from our data, as we may have greater power to detect structure along some axes 302 14 than others due to the unequal distribution of surrounding countries in publicly available samples, 303 although in general we have good representation in both the East-West and North-South directions. 304
305
The flexible nature of MIP panels allows for multiplex detection of SNPs associated with drug 306 resistance in any known or putative resistance loci for which they are designed. This allowed for a more 307 detailed evaluation of molecular markers associated with antimalarial resistance than has previously 308 been possible in the DRC. To date, studies of antimalarial resistance markers in the DRC have 309 focused primarily on pfcrt (K76T), dhfr (N51I, C59R, S108N, I164L), dhps (I431V, S436A, A437G, 310 K540E, A581G, A613S), pfmdr (N86Y, F184Y, D1246Y), and a few kelch mutations 23-29 . The data 311 suggests that mutations associated with artemisinin resistance remained absent in the country as of 312 2014. The World Health Organization identified 9 mutations within the K13 propeller region that are 313 validated in terms of their clinical phenotype of artemisinin resistance, and a further 11 mutations that 314 are candidates associated with the phenotype of delayed clearance. 30 We identified 14 mutations within 315 the K13 gene ( Supplemental Table 2 ), although none of these correspond to validated or candidate 316 artemisinin resistance mutations. 317 318 Beyond looking at mutations within drug resistance genes, differences in extended haplotypes around 319 drug resistance genes have been used to understand evolution and spread 31 . Though not originally 320 designed for this purpose, the genome wide MIP panel can be leveraged for conducting similar 321 analyses. For example, the differences in CVIET EHH between the West and East suggests that the 322 CVIET haplotype in the West has potentially been more recently introduced, has experienced less 323 breakdown through recombination, or has undergone stronger recent positive selection as compared to 324 the East. Redesign of the selected targets with denser sampling around known drug resistance genes 325 will allow for more robust assessment of these selected regions. Table 1 ). The genomic sequence from these samples underwent alignment, variant 363 calling, and variant-filtering following the Pf3k strategy consistent with the Genome Analysis Toolkit 364 (GATK) Best Practices with minor modifications 37-40 . Full details of the bioinformatic pipeline used in 365 MIP design are given in the Supplemental Text. Samples from Nigeria and Uganda were dropped 366 after variant calling due to small sample sizes, and the final filtered sequences were used to calculate 367
Weir and Cochran's FST 41 with respect to country for each biallelic locus. The 1,000 loci with the highest 368 FST values were considered for MIP design as phylogeographically informative loci. Of these 1,000 369 potential loci, 739 were identified as regions that were suitable for MIP-probe design. Separately, from 370 the combined SNP file, we identified 1595 loci that had a minor-allele frequency greater than 5%, had 371
